Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

Combination HCV therapy receives priority classification from FDA

Jan. 21, 1998

Interim Maxamine phase I data reported

Jan. 19, 1998

Vertex researchers report 3-D structure of hepatitis C enzyme

Jan. 19, 1998

Overview of antiviral agents in hepatic disease

Jan. 15, 1998

Novel binding mechanism described for Shin Nippon's H+/K+-ATPase inhibitor

Jan. 12, 1998

New antiulcer agent now available in Japan

Jan. 9, 1998

Astra to launch new tablet formulation of Losec in Sweden

Jan. 7, 1998

Clinical pharmacodynamic profile of 5-HT4 agonist

Jan. 5, 1998

Avakine submitted for FDA review

Jan. 2, 1998

FR-208419: a new dual CCK-A and CCK-B/gastrin receptor antagonist

Dec. 31, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...